Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa

aHarvard T.H. Chan School of Public Health, Boston, Massachusetts

bDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

cAurum Institute

dUniversity of Witwatersrand, Johannesburg, South Africa

eDivision of Infectious Diseases, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.

Correspondence to Ruchita Balasubramanian, Harvard University HSPH: Harvard University T.H. Chan School of Public Health, Boston, MA 02115, USA. E-mail: [email protected]

Received 23 May, 2023

Revised 21 August, 2023

Accepted 25 August, 2023

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).

Comments (0)

No login
gif